Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood test can predict long-term risk of death in patients with shortness of breath

14.02.2006


Researchers from Massachusetts General Hospital (MGH) have shown that a blood test previously found useful for diagnosing heart failure and determining prognosis in several cardiovascular conditions can also predict the risk of death among patients coming to hospital emergency departments with shortness of breath. Their report in the Feb. 14 Archives of Internal Medicine describes how measuring levels of a protein called NT-proBNP was the most powerful predictor of whether patients would die within the year.


"We found that, regardless of whether the patient had been diagnosed with heart failure, elevated levels of this protein were strongly prognostic for death at one year and low levels identified those at the lowest risk," says James Januzzi Jr., MD, of the MGH Cardiology Division, the paper’s lead author. "Based on these results, we recommend that every patient coming to a hospital with shortness of breath be tested for NT-proBNP."

NT-proBNP is a natriuretic peptide, a protein produced when the cardiac muscle is under stress. In recent years these proteins have been investigated as assays for various forms of cardiovascular disease. In April 2005, members of the same MGH research team published the PRIDE study, which enrolled almost 600 patients who came to the MGH Emergency Department with shortness of breath. The PRIDE study showed that emergency department testing for NT-proBNP could help diagnose heart failure in those patients, providing a definitive diagnosis when the result was above specific levels and ruling it out when results were below an identified point.

The current study, designed to evaluate the long-term prognostic usefulness of the test, followed up on the patients in the PRIDE study. The research team contacted primary care physicians or cardiologists for each of the study participants, or reviewed hospital records, to determine their status a year after the original emergency visit. The results, which included data from all but four of the PRIDE study participants, showed that the NT-proBNP measurement made in the emergency department was a more accurate predictor of the risk of death during the following year than were other known measurements of cardiac risk.



"One of the more impressive findings in our study was the remarkably strong prognostic ability of NT-proBNP measurement in patients with shortness of breath from all causes," Januzzi added. "An elevated NT-proBNP was as strong a predictor of death in patients without heart failure as it was for those with it. And remarkably, among those found to have heart failure in the original visit, no patient with an NT-proBNP level below a certain point died during the study period.

"Elevations of NT-proBNP can be used not only to determine the diagnosis and the best hospital setting for treatment but also to estimate longer-term prognosis, allowing us to identify patients needing more intensive treatment and follow-up," he adds. "The next logical step is to evaluate treatment interventions for those with higher NT-proBNP levels to see if we can reduce their considerable risk for death." Januzzi is currently directing a randomized clinical trial of medical therapy guided by NT-proBNP measurement for patients with recent heart failure.

The study’s coauthors are Rahul Sakhuja, MD, MPP, Michelle O’Donoghue, MD, Aaron Baggish, MD, Saif Anwaruddin, MD, Claudia Chae, MD, MPH, Renee Cameron, Daniel Krauser, MD, Roderick Tung, MD, and Carlos Camargo Jr., MD, of MGH, and Donald Lloyd-Jones, MD, ScM, of the Feinberg School of Medicine at Northwestern University. The study was supported by a grant from Roche Diagnostics, which manufacturers the NT-proBNP assay studied but had no role in conducting the investigation or reporting the results.

Sue McGreevey | EurekAlert!
Further information:
http://www.mgh.harvard.edu/

More articles from Health and Medicine:

nachricht A promising target for kidney fibrosis
21.04.2017 | Brigham and Women's Hospital

nachricht Stem cell transplants: activating signal paths may protect from graft-versus-host disease
20.04.2017 | Technische Universität München

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

DGIST develops 20 times faster biosensor

24.04.2017 | Physics and Astronomy

Nanoimprinted hyperlens array: Paving the way for practical super-resolution imaging

24.04.2017 | Materials Sciences

Atomic-level motion may drive bacteria's ability to evade immune system defenses

24.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>